Odds of ischaemic optic neuropathy nearly 5 times higher than among users of Ozempic And 3 times higher in men than in women, analysis of unintended side effect reports shows Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of ‘eye stroke’ (ischaemic optic neuropathy) and sudden ...
Findings suggest a potential role in both prevention and treatment of various substance use disorders, say researchers Glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity may also help to lower the risk of addiction to a range of substances including alcohol, cannabis, cocaine, nicotine, and ...
Weekend catch-ups linked to heightened risk of insulin resistance in those sleeping more Sleeping for 7 hours and 18 minutes every night may be the sweet spot for warding off the risk of insulin resistance—the precursor to type 2 diabetes—suggests a large observational study published in the open access journal BMJ ...
The BMJ research: sodium-glucose cotransporter-2 inhibitors and risk of autoimmune rheumatic diseases In October 2025, The BMJ published the first nationwide population based cohort study to examine the association between sodium-glucose cotransporter-2 (SGLT2) inhibitors and risk of autoimmune rheumatic diseases (ARDs). Drawing on data from more than ...
Copyright © 2026 BMJ Publishing Group Limited. All rights reserved.
Cookie settings | Accessibility | Cookie policy | Modern Slavery Statement | Privacy policy | Website terms and conditions
